Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Zoledronate compared to other bisphosphonates in rat models of bone loss

Feb. 10, 1998

MMAS results discussed at world congress

Feb. 10, 1998

Pernasal testosterone: a novel administration route for androgenic substitution

Feb. 9, 1998

MENT: summary of concept data and preclinical and clinical results

Feb. 9, 1998

Antiobesity and antidiabetic compounds claimed by American Home Products

Feb. 6, 1998

Boehringer Mannheim develops new agents for diabetes

Feb. 6, 1998

Zestril introduced for new indication in U.K.

Feb. 5, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Androtab-SL NDA is inadequate for approval, FDA says

Feb. 3, 1998

EPO peptides and anti-EPO antibodies from Behringwerke

Feb. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...